Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (Zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer
暂无分享,去创建一个
D. Farrar | R. Clayton | T. Perren | G. Blackledge | L. C. Bailey | G. Holder | S. Lynch | D. Arkell | J. Cottam | C. Young